HSLSX | NRGSX | HSLSX / NRGSX | |
Total Expense Ratio | 1.27 | 0.74 | 172% |
Annual Report Gross Expense Ratio | 1.27 | 0.74 | 172% |
Fund Existence | 19 years | 13 years | - |
Gain YTD | 4.992 | -2.770 | -180% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 302M | 8.85B | 3% |
Annual Yield % from dividends | 1.12 | 0.06 | 1,731% |
Returns for 1 year | -7.15 | -7.08 | 101% |
Returns for 3 years | 21.75 | 10.58 | 206% |
Returns for 5 years | -20.13 | -0.74 | 2,717% |
Returns for 10 years | -9.63 | 10.64 | -90% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PRIAX | 35.39 | N/A | N/A |
Principal Glb Emerging Markets A | |||
CVMAX | 22.42 | N/A | N/A |
Calvert Emerging Markets Equity A | |||
GMCUX | 17.15 | N/A | N/A |
Goldman Sachs Small/Mid Cap Equity R6 | |||
CECYX | 30.47 | -0.07 | -0.23% |
Columbia Large Cap Enhanced Core Inst3 | |||
AFMBX | 38.95 | -0.14 | -0.36% |
American Funds American Balanced F3 |